Pharma Deal Signal Monitor

High-Level Intelligence for Pharma BD

The Pharma Deal Signal Monitor is a targeted intelligence tool designed for Business Development (BD) professionals, venture capitalists, and licensing scouts. It solves the "manual monitoring" problem by automatically scanning the latest pharmaceutical press releases for high-intent signals that a company is ready to transact.

What it does

This skill performs a multi-vector sweep across the Pharmaceutic Index corpus, analyzing seven distinct categories of deal signals: positive clinical readouts, regulatory milestones, asset reversions, new leadership hires, capital raises, IND filings, and explicit partnering language. It doesn't just surface news; it synthesizes findings into a ranked Deal Signal Report that highlights "Compound Signals"—companies appearing in multiple categories who are most likely to be seeking partners.

Why use this skill?

• Go Beyond Keywords: Uses semantic search to find the *concept* of a deal signal rather than just matching text, catching signals human scouts might miss.
• Identify Early Transitions: Flags termination of prior collaborations and asset reversions, surfacing opportunities before they become public knowledge.
• Automated BD Pipeline: Turns raw industry news into a curated list of actionable leads categorized by strategic intent.
• MCP Integration: Connects directly to real-time pharma data via the Pharmaceutic Index MCP server.

Supported Output

Each run produces a structured report including company names, specific asset details, indications, development phases, and the key evidentiary passages from the source material, all ranked by signal strength.